{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:43:15Z","timestamp":1791265395448,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2011-0021670"],"award-info":[{"award-number":["2011-0021670"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003627","name":"Rural Development Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003627","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ijantimicag.2013.08.011","type":"journal-article","created":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T02:07:41Z","timestamp":1379902061000},"page":"544-552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative activities of selected fluoroquinolones against dynamic populations of Actinobacillus pleuropneumoniae in an in vitro model of time\u2013kill continuous culture experiment"],"prefix":"10.1016","volume":"42","author":[{"given":"Dereje","family":"Damte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sileshi B","family":"Yohannes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Akil","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Won","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Chun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/mdr.2011.0150","article-title":"Antimicrobial susceptibilities and resistance genes of Canadian isolates of Actinobacillus pleuropneumoniae","volume":"18","author":"Archambault","year":"2012","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0010","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/AAC.45.4.999-1007.2001","article-title":"Riddle of biofilm resistance","volume":"45","author":"Lewis","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0015","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1097\/CCM.0b013e318180fe62","article-title":"Antibiotic resistance\u2014what's dosing got to do with it?","volume":"36","author":"Roberts","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0020","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1939-1676.2006.tb00742.x","article-title":"Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats","volume":"20","author":"Boothe","year":"2006","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.vetmic.2007.03.017","article-title":"Comparative quantification of the in vitro activity of veterinary fluoroquinolones","volume":"124","author":"Grobbel","year":"2007","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0030","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1128\/AAC.49.10.4166-4173.2005","article-title":"Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance","volume":"49","author":"Wetzstein","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0035","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1128\/AAC.06486-11","article-title":"In vivo pharmacokinetics\/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection","volume":"56","author":"Hengzhuang","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0040","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1128\/AAC.00126-11","article-title":"Pharmacokinetics\/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms","volume":"55","author":"Hengzhuang","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0045","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/jac\/dkl135","article-title":"Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration","volume":"57","author":"Olofsson","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/AAC.48.2.369-377.2004","article-title":"Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC","volume":"48","author":"Mueller","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0055","doi-asserted-by":"crossref","first-page":"e38866","DOI":"10.1371\/journal.pone.0038866","article-title":"Staphylococcus aureus in continuous culture: a tool for the rational design of antibiotic treatment protocols","volume":"7","author":"Udekwu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1292\/jvms.63.341","article-title":"Antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Korea using new standardized procedures","volume":"63","author":"Kim","year":"2001","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0065","series-title":"Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard. 2nd ed. Document M31-A2","author":"Clinical and Laboratory Standards Institute","year":"2002"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0070","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1099\/jmm.0.028654-0","article-title":"Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin\/marbofloxacin-selected mutants of Escherichia coli of canine origin","volume":"60","author":"Gebru","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0075","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1128\/AAC.47.5.1604-1613.2003","article-title":"In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus","volume":"47","author":"Firsov","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2885.2009.01123.x","article-title":"Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs","volume":"33","author":"Bimazubute","year":"2010","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0085","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2885.2008.00951.x","article-title":"Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications","volume":"31","author":"Ding","year":"2008","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0090","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2885.2010.01164.x","article-title":"Plasma and tissue cage fluid pharmacokinetics of marbofloxacin after intravenous, intramuscular, and oral single-dose application in pigs","volume":"33","author":"Ding","year":"2010","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0095","series-title":"Tabulation of FARAD comparative and veterinary pharmacokinetic data","first-page":"719","article-title":"Fluoroquinolones","author":"Craigmill","year":"2006"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0100","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.vetmic.2011.07.033","article-title":"Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs","volume":"154","author":"Gebru","year":"2012","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.vetmic.2009.09.067","article-title":"Molecular characterization of enrofloxacin resistant Actinobacillus pleuropneumoniae isolates","volume":"142","author":"Wang","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0110","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1128\/AAC.00381-10","article-title":"Population dynamics of antibiotic treatment: a mathematical model and hypotheses for time\u2013kill and continuous-culture experiments","volume":"54","author":"Levin","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0115","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1128\/JB.186.24.8172-8180.2004","article-title":"Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli","volume":"186","author":"Keren","year":"2004","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tim.2004.11.010","article-title":"Survival strategies of infectious biofilms","volume":"13","author":"Fux","year":"2005","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0125","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/AAC.05964-11","article-title":"Comparative pharmacodynamics and antimutant potentials of doripenem and imipenem with ciprofloxacin-resistant Pseudomonas aeruginosa in an in vitro model","volume":"56","author":"Firsov","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0130","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1128\/AAC.00182-11","article-title":"Pharmacokinetic\/pharmacodynamic (PK\/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization","volume":"55","author":"Nielsen","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0135","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2460\/ajvr.1999.60.11.1377","article-title":"Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs","volume":"60","author":"Anad\u00f3n","year":"1999","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0140","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/004982598239128","article-title":"Pharmacokinetic properties and oral bioavailabilities of difloxacin in pig and chicken","volume":"28","author":"Inui","year":"1998","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0145","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/AAC.40.2.491","article-title":"Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli","volume":"40","author":"Vila","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.08.011_bib0150","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1128\/AAC.39.5.1134","article-title":"In vivo verification of in vitro model of antibiotic treatment of device-related infection","volume":"39","author":"Blaser","year":"1995","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913003063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913003063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:31:07Z","timestamp":1760376667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857913003063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0924857913003063"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.08.011","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative activities of selected fluoroquinolones against dynamic populations of Actinobacillus pleuropneumoniae in an in vitro model of time\u2013kill continuous culture experiment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}